Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 74,502,096
- Share change
- +741,731
- Total reported value
- $175,824,000
- Price per share
- $2.36
- Number of holders
- 14
- Value change
- +$1,768,228
- Number of buys
- 11
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
52%
|
72,803,072
|
$87,080,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.45%
|
627,690
|
$751,000 | — | 31 Dec 2020 | |
| Bruce & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
182,972
|
$217,000 | — | 31 Dec 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
150,000
|
$179,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
67,056
|
$80,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.03%
|
44,170
|
$53,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
21,607
|
$26,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
18,506
|
$22,000 | — | 31 Dec 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
14,542
|
$17,000 | — | 31 Dec 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
11,951
|
$14,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,262
|
$2,000 | — | 31 Dec 2020 | |
| Winslow, Evans & Crocker, Inc. |
13F
|
Company |
0%
|
1,258
|
$2,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
511
|
$1,000 | — | 31 Dec 2020 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q1 2021
As of 31 Mar 2021,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
74,502,096 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), MARSHALL WACE, LLP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, HRT FINANCIAL LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
11
Q1 2021 holders
14
Holder diff
3
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.